More about human monocytotropic ehrlichiosis in Brazil: serological evidence of nine new cases.

Human Ehrlichia chaffeensis infections have been reported in North America, Asia and Europe, but only recently have human cases been reported in Brazil. Nine new human cases of E. chaffeensis infection diagnosed on a clinical and serological basis are reported. Serological tests were performed with indoor slides prepared with CDC stock DH-82 cells infected with E. chaffeensis (Arkansas strain). All but two patients were adults. Seven patients were male and two female. The fever duration varied from 4 to 120 days with a median of 6 days. All patients recalled previous tick attack. IgM was detected in four cases. Influenza like syndrome was the most frequent clinical form affecting five patients. Two patients had fever of unknown origin (FUO), one patient had blood culture-negative endocarditis and one had encephalitis. All patients except one recovered. Two patients were correctly treated. One patient with FUO had AIDS and unexplained pancytopenia. The occurrence of human ehrlichiosis by E. chaffeensis remains to be proved in Brazil; the cases reported here highlight the possibility of such disease occurrence in Brazil.

Questing one Brazilian query: reporting 16 cases of Q fever from Minas Gerais, Brazil.

Q fever has been considered non-existing in Brazil where reports of clinical cases still cannot be found. This case-series of 16 patients is a result of a systematic search for such illness by means of clinical and serologic criteria. Serologic testing was performed by the indirect microimmunofluorescence technique using phase I/II C. burnetii antigens. Influenza-like syndrome was the most frequent clinical form (eight cases--50%), followed by pneumonia, FUO (fever of unknown origin), mono-like syndrome (two cases--12.5% each), lymphadenitis (one case--6.3%) and spondylodiscitis associated with osteomyelitis (one case--6.3%). The ages varied from four to 67 years old with a median of 43.5. All but one patient had positive serologic tests for phase II IgG whether or not associated with IgM positivity compatible with acute infection. One patient had both phase I and phase II IgG antibodies compatible with chronic Q fever. Seroconvertion was detected in 10 patients. Despite the known limitations of serologic diagnosis, the cases here reported should encourage Brazilian doctors to include Q fever as an indigenous cause of febrile illness.

Questing one Brazilian query: reporting 16 cases of Q fever from Minas Gerais, Brazil

A febre Q continua sendo considerada inexistente no Brasil onde publicações de casos clínicos ainda não são encontráveis. Esta série de casos de 16 pacientes é resultado de uma busca sistemática para esta doença usando-se critérios clínicos e sorológicos. Os testes sorológicos foram realizados pela técnica de microimunofluorescência indireta utilizando-se antígenos de C. burnetii fase I e fase II. Síndrome influenza símile foi a forma clínica mais frequente (oito casos - 50%), seguida pela pneumonia, FOI (febre de origem indeterminada), síndrome mononucleose símile (dois casos - 12,5% cada) e por fim linfoadenite (um caso - 6,3%) e espondilodiscite associada à osteomielite (um caso - 6,3%). As idades variaram de quatro a 67 anos com mediana de 43,5. Todos os pacientes, com exceção de um, tinham testes sorológicos positivos para IgG anti fase II, associado ou não a IgM anti fase II, compatíveis com infecção aguda. Um paciente tinha tanto anticorpos IgG anti fase I quanto anti fase II compatíveis com febre Q crônica. Soroconversão foi detectada em 10 pacientes. A despeito das conhecidas limitações do diagnóstico sorológico os casos aqui relatados devem encorajar os médicos brasileiros a incluir a febre Q como causa nativa de doença febril neste país a ser pesquisada.

More about human monocytotropic ehrlichiosis in Brazil: serological evidence of nine new cases

Human Ehrlichia chaffeensis infections have been reported in North America, Asia and Europe, but only recently have human cases been reported in Brazil. Nine new human cases of E. chaffeensis infection diagnosed on a clinical and serological basis are reported. Serological tests were performed with indoor slides prepared with CDC stock DH-82 cells infected with E. chaffeensis (Arkansas strain). All but two patients were adults. Seven patients were male and two female. The fever duration varied from 4 to 120 days with a median of 6 days. All patients recalled previous tick attack. IgM was detected in four cases. Influenza like syndrome was the most frequent clinical form affecting five patients. Two patients had fever of unknown origin (FUO), one patient had blood culture-negative endocarditis and one had encephalitis. All patients except one recovered. Two patients were correctly treated. One patient with FUO had AIDS and unexplained pancytopenia. The occurrence of human ehrlichiosis by E. chaffeensis remains to be proved in Brazil; the cases reported here highlight the possibility of such disease occurrence in Brazil.